The Combined Clinical Efficacy and Safety Analysis of Adoptive Immunotherapy with Radiotherapy and Chemotherapy in Non-Small-Cell Lung Cancer: Systematic Review and Meta-Analysis

Objective. To explore the differential efficacy of chemoradiotherapy combined with adoptive immunotherapy and radiochemotherapy alone in patients with non-small-cell lung cancer (NSCLC). Methods. Qualified randomized controlled trial (randomized controlled trial, RCT), or nonrandomized concurrent co...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Applied bionics and biomechanics 2022-06, Vol.2022, p.2731744-8
Hauptverfasser:	Fan, Zhiming, He, Honggui, Chen, Liqun
Format:	Artikel
Sprache:	eng
Schlagworte:	Adoptive immunotherapy Bias Cancer Cancer therapies Chemoradiotherapy Chemotherapy Cytokines Data analysis Development and progression Immunotherapy Information management Lung cancer Lung cancer, Non-small cell Lymphocytes Medical prognosis Meta-analysis Non-small cell lung carcinoma Patients Radiation therapy Radiotherapy Small cell lung carcinoma Software Statistical analysis Survival
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Objective. To explore the differential efficacy of chemoradiotherapy combined with adoptive immunotherapy and radiochemotherapy alone in patients with non-small-cell lung cancer (NSCLC). Methods. Qualified randomized controlled trial (randomized controlled trial, RCT), or nonrandomized concurrent controlled trial (NRCCT), published in various databases, including PubMed, EMBASE, Chinese journal full-text database, Medline, Cochrane database, and VIP Chinese database, and the Revman5. 0 software performed the data analysis. Results. We found the significantly different curative effect between the experimental and control groups (OR=1.94, 95% CI (1.46, 2.58), P
ISSN:	1176-2322 1754-2103
DOI:	10.1155/2022/2731744